Table 2.
Characteristic | Total | % | 5-yr FFS (%) | p-value |
---|---|---|---|---|
Age | ||||
< 3 months | 13 | 17 | 59 | 0.86 |
≥ 3 months | 63 | 83 | 56 | |
Site | ||||
Favorable | 29 | 38 | 52 | 0.43 |
Unfavorable | 43 | 57 | 61 | |
Histology | ||||
Embryonal | 43 | 57 | 64 | 0.04 |
Alveolar | 16 | 21 | 22 | |
UDS/Other | 17 | 22 | 69 | |
Tumor Size | ||||
≤ 5cm | 45 | 59 | 59 | 0.86 |
> 5cm | 31 | 41 | 54 | |
T-Stage | ||||
T-1 | 45 | 59 | 59 | 0.48 |
T-2 | 31 | 41 | 53 | |
Nodes | ||||
N0 | 63 | 84 | 56 | 0.97 |
N1 | 9 | 12 | 65 |
Favorable Site: non-parameningeal Head & Neck, Orbit, GU non-Bladder/Prostate
Unfavorable Site: Parameningeal, Extremity, Trunk/Abdomen, Bladder/Prostate
UDS, undifferentiated sarcoma